Clinical Trial Update: Surgery Vs Chemoradiation for Oropharyngeal Cancer- A Phase II/III Integrated Design Randomized Control Trial [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial comparing surgery versus chemoradiation for stage III/IV p16-negative oropharyngeal cancer in an integrated Phase 2/3 design; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Cancer

Snippet

Sponsor: Tata Memorial Centre | Conditions: Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING